InvestorsHub Logo
Post# of 252400
Next 10
Followers 0
Posts 75
Boards Moderated 0
Alias Born 03/22/2004

Re: None

Wednesday, 12/08/2010 11:27:21 AM

Wednesday, December 08, 2010 11:27:21 AM

Post# of 252400
Oncologic Drugs AdComm
Meeting Date: 2/9/11-2/9/11

On February 9, 2011, the committee will discuss biologics license application (BLA) 125377, with the proposed trade name YERVOY (ipilimumab), submitted by Bristol-Myers Squibb Co.. The proposed indication (use) for this product is for the treatment of advanced melanoma in patients who have received ...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.